Capstone Investment Advisors
WST icon

Capstone Investment Advisors’s West Pharmaceutical WST Stock Holding History

Capstone Investment Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,419
Closed -$465K – 1921
2024
Q4 		$465K Sell
1,419
-621
-30% -$195K ﹤0.01% 1340
2024
Q3 		$612K Sell
2,040
-731
-26% -$224K ﹤0.01% 1138
2024
Q2 		$913K Buy
2,771
+785
+40% +$277K ﹤0.01% 1029
2024
Q1 		$786K Sell
1,986
-272
-12% -$101K ﹤0.01% 1289
2023
Q4 		$795K Buy
+2,258
New +$799K ﹤0.01% 1140
2023
Q3 		– Sell
-883
Closed -$341K – 2313
2023
Q2 		$338K Buy
+883
New +$315K ﹤0.01% 1342
2018
Q1 		– Sell
-3,760
Closed -$370K – 555
2017
Q4 		$370K Buy
+3,760
New +$369K 0.01% 325
2017
Q3 		– Sell
-21,760
Closed -$2.06M – 758
2017
Q2 		$2.06M Buy
21,760
+2,756
+15% +$253K 0.06% 247
2017
Q1 		$1.55M Buy
+19,004
New +$1.59M 0.04% 335
2016
Q4 		– Sell
-18,995
Closed -$1.42M – 1133
2016
Q3 		$1.42M Buy
+18,995
New +$1.51M 0.03% 319

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Capstone Investment Advisors's WST Position: Q1 2025 in Review

Capstone Investment Advisors sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 1,419 shares — an estimated $465K sold.

Capstone Investment Advisors first reported a position in WST in Q3 2016 and held it in 10 quarters. The position peaked at $2.06M in Q2 2017. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Capstone Investment Advisors reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 1,419 West Pharmaceutical shares in Q1 2025, an estimated $465K.
  • Capstone Investment Advisors first reported a position in West Pharmaceutical in Q3 2016 and held it in 10 quarters.
  • Capstone Investment Advisors's West Pharmaceutical position peaked at $2.06M in Q2 2017.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Capstone Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.